PHIO · Phio Pharmaceuticals Corp.

Summary

Phio Pharmaceuticals Corp. entered into the Second Amendment to the Employment Agreement of President and CEO Robert J. Bitterman on February 17, 2026. The amendment increases his annual target bonus opportunity to 50% of base salary from 40% and extends severance to 12 months of base salary upon termination without cause or for good reason.

Key takeaways

• Second Amendment to Employment Agreement executed February 17, 2026
• Robert J. Bitterman, President and CEO
• Annual target bonus increased to 50% of base salary from 40%
• Severance provision amended to 12 months base salary
• Applies to termination without cause or for good reason
• Filed as Exhibit 10.1